Cytogenetic Arrays - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509245464

Publication Date:

September 30, 2024

Pages:

104

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Semiconductors [2]

Computing & Electronics [3]

Description:

A cytogenetic array, also known as a chromosomal microarray or array-based comparative genomic hybridization (aCGH), is a type of genetic testing technology used to detect and analyze chromosomal abnormalities, such as gains or losses of genetic material.
Cytogenetic chips work by hybridizing small fragments of DNA from a patient's genome onto a glass slide or chip that contains known DNA probes that cover the entire human genome. By measuring the amount of hybridization between the patient's DNA fragments and the probes on the chip, the test can identify and locate chromosomal abnormalities with high resolution. The results of a cytogenetic chip test can be used to diagnose genetic disorders, such as developmental delays, intellectual disabilities, and birth defects, and to inform medical management and genetic counseling.
Cytogenetic chips are commonly used in clinical genetics and prenatal testing, and are often considered a first-line test for detecting chromosomal abnormalities. They have largely replaced traditional karyotyping, a method for visualizing chromosomes under a microscope, due to their higher resolution and ability to detect smaller chromosomal abnormalities.
The global market for Cytogenetic Arrays was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global market for semiconductor was estimated at US$ 579 billion in the year 2022, is projected to US$ 790 billion by 2029, growing at a CAGR of 6% during the forecast period. Although some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.76%, Sensor with 16.31%, and Logic with 14.46% growth, Memory declined with 12.64% year over year. The microprocessor (MPU) and microcontroller (MCU) segments will experience stagnant growth due to weak shipments and investment in notebooks, computers, and standard desktops. In the current market scenario, the growing popularity of IoT-based electronics is stimulating the need for powerful processors and controllers. Hybrid MPUs and MCUs provide real-time embedded processing and control for the topmost IoT-based applications, resulting in significant market growth. The Analog IC segment is expected to grow gradually, while demand from the networking and communications industries is limited. Few of the emerging trends in the growing demand for Analog integrated circuits include signal conversion, automotive-specific Analog applications, and power management. They drive the growing demand for discrete power devices.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cytogenetic Arrays, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cytogenetic Arrays by region & country, by Type, and by Application.
The Cytogenetic Arrays market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytogenetic Arrays.
Market Segmentation
By Company
Illumina
Thermo Fisher
Oxford Nanopore
PacBio
Roche
PerkinElmer
SHBIO
Agilent
Segment by Type:
Whole-Genome Sequencing Arrays
Comparative Genomic Hybridization (CGH) Arrays
Others
Segment by Application
Assisted Reproduction
Scientific Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cytogenetic Arrays manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cytogenetic Arrays in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cytogenetic Arrays in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Cytogenetic Arrays Product Introduction
1.2 Global Cytogenetic Arrays Market Size Forecast
1.2.1 Global Cytogenetic Arrays Sales Value (2019-2030)
1.2.2 Global Cytogenetic Arrays Sales Volume (2019-2030)
1.2.3 Global Cytogenetic Arrays Sales Price (2019-2030)
1.3 Cytogenetic Arrays Market Trends & Drivers
1.3.1 Cytogenetic Arrays Industry Trends
1.3.2 Cytogenetic Arrays Market Drivers & Opportunity
1.3.3 Cytogenetic Arrays Market Challenges
1.3.4 Cytogenetic Arrays Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cytogenetic Arrays Players Revenue Ranking (2023)
2.2 Global Cytogenetic Arrays Revenue by Company (2019-2024)
2.3 Global Cytogenetic Arrays Players Sales Volume Ranking (2023)
2.4 Global Cytogenetic Arrays Sales Volume by Company Players (2019-2024)
2.5 Global Cytogenetic Arrays Average Price by Company (2019-2024)
2.6 Key Manufacturers Cytogenetic Arrays Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cytogenetic Arrays Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cytogenetic Arrays
2.9 Cytogenetic Arrays Market Competitive Analysis
2.9.1 Cytogenetic Arrays Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cytogenetic Arrays Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytogenetic Arrays as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Whole-Genome Sequencing Arrays
3.1.2 Comparative Genomic Hybridization (CGH) Arrays
3.1.3 Others
3.2 Global Cytogenetic Arrays Sales Value by Type
3.2.1 Global Cytogenetic Arrays Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cytogenetic Arrays Sales Value, by Type (2019-2030)
3.2.3 Global Cytogenetic Arrays Sales Value, by Type (%) (2019-2030)
3.3 Global Cytogenetic Arrays Sales Volume by Type
3.3.1 Global Cytogenetic Arrays Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cytogenetic Arrays Sales Volume, by Type (2019-2030)
3.3.3 Global Cytogenetic Arrays Sales Volume, by Type (%) (2019-2030)
3.4 Global Cytogenetic Arrays Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Assisted Reproduction
4.1.2 Scientific Research
4.1.3 Others
4.2 Global Cytogenetic Arrays Sales Value by Application
4.2.1 Global Cytogenetic Arrays Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cytogenetic Arrays Sales Value, by Application (2019-2030)
4.2.3 Global Cytogenetic Arrays Sales Value, by Application (%) (2019-2030)
4.3 Global Cytogenetic Arrays Sales Volume by Application
4.3.1 Global Cytogenetic Arrays Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cytogenetic Arrays Sales Volume, by Application (2019-2030)
4.3.3 Global Cytogenetic Arrays Sales Volume, by Application (%) (2019-2030)
4.4 Global Cytogenetic Arrays Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cytogenetic Arrays Sales Value by Region
5.1.1 Global Cytogenetic Arrays Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cytogenetic Arrays Sales Value by Region (2019-2024)
5.1.3 Global Cytogenetic Arrays Sales Value by Region (2025-2030)
5.1.4 Global Cytogenetic Arrays Sales Value by Region (%), (2019-2030)
5.2 Global Cytogenetic Arrays Sales Volume by Region
5.2.1 Global Cytogenetic Arrays Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cytogenetic Arrays Sales Volume by Region (2019-2024)
5.2.3 Global Cytogenetic Arrays Sales Volume by Region (2025-2030)
5.2.4 Global Cytogenetic Arrays Sales Volume by Region (%), (2019-2030)
5.3 Global Cytogenetic Arrays Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cytogenetic Arrays Sales Value, 2019-2030
5.4.2 North America Cytogenetic Arrays Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cytogenetic Arrays Sales Value, 2019-2030
5.5.2 Europe Cytogenetic Arrays Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cytogenetic Arrays Sales Value, 2019-2030
5.6.2 Asia Pacific Cytogenetic Arrays Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cytogenetic Arrays Sales Value, 2019-2030
5.7.2 South America Cytogenetic Arrays Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cytogenetic Arrays Sales Value, 2019-2030
5.8.2 Middle East & Africa Cytogenetic Arrays Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cytogenetic Arrays Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cytogenetic Arrays Sales Value
6.2.1 Key Countries/Regions Cytogenetic Arrays Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cytogenetic Arrays Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cytogenetic Arrays Sales Value, 2019-2030
6.3.2 United States Cytogenetic Arrays Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cytogenetic Arrays Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cytogenetic Arrays Sales Value, 2019-2030
6.4.2 Europe Cytogenetic Arrays Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cytogenetic Arrays Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cytogenetic Arrays Sales Value, 2019-2030
6.5.2 China Cytogenetic Arrays Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cytogenetic Arrays Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cytogenetic Arrays Sales Value, 2019-2030
6.6.2 Japan Cytogenetic Arrays Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cytogenetic Arrays Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cytogenetic Arrays Sales Value, 2019-2030
6.7.2 South Korea Cytogenetic Arrays Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cytogenetic Arrays Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cytogenetic Arrays Sales Value, 2019-2030
6.8.2 Southeast Asia Cytogenetic Arrays Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cytogenetic Arrays Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cytogenetic Arrays Sales Value, 2019-2030
6.9.2 India Cytogenetic Arrays Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cytogenetic Arrays Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Illumina
7.1.1 Illumina Company Information
7.1.2 Illumina Introduction and Business Overview
7.1.3 Illumina Cytogenetic Arrays Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Illumina Cytogenetic Arrays Product Offerings
7.1.5 Illumina Recent Development
7.2 Thermo Fisher
7.2.1 Thermo Fisher Company Information
7.2.2 Thermo Fisher Introduction and Business Overview
7.2.3 Thermo Fisher Cytogenetic Arrays Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Thermo Fisher Cytogenetic Arrays Product Offerings
7.2.5 Thermo Fisher Recent Development
7.3 Oxford Nanopore
7.3.1 Oxford Nanopore Company Information
7.3.2 Oxford Nanopore Introduction and Business Overview
7.3.3 Oxford Nanopore Cytogenetic Arrays Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Oxford Nanopore Cytogenetic Arrays Product Offerings
7.3.5 Oxford Nanopore Recent Development
7.4 PacBio
7.4.1 PacBio Company Information
7.4.2 PacBio Introduction and Business Overview
7.4.3 PacBio Cytogenetic Arrays Sales, Revenue and Gross Margin (2019-2024)
7.4.4 PacBio Cytogenetic Arrays Product Offerings
7.4.5 PacBio Recent Development
7.5 Roche
7.5.1 Roche Company Information
7.5.2 Roche Introduction and Business Overview
7.5.3 Roche Cytogenetic Arrays Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Roche Cytogenetic Arrays Product Offerings
7.5.5 Roche Recent Development
7.6 PerkinElmer
7.6.1 PerkinElmer Company Information
7.6.2 PerkinElmer Introduction and Business Overview
7.6.3 PerkinElmer Cytogenetic Arrays Sales, Revenue and Gross Margin (2019-2024)
7.6.4 PerkinElmer Cytogenetic Arrays Product Offerings
7.6.5 PerkinElmer Recent Development
7.7 SHBIO
7.7.1 SHBIO Company Information
7.7.2 SHBIO Introduction and Business Overview
7.7.3 SHBIO Cytogenetic Arrays Sales, Revenue and Gross Margin (2019-2024)
7.7.4 SHBIO Cytogenetic Arrays Product Offerings
7.7.5 SHBIO Recent Development
7.8 Agilent
7.8.1 Agilent Company Information
7.8.2 Agilent Introduction and Business Overview
7.8.3 Agilent Cytogenetic Arrays Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Agilent Cytogenetic Arrays Product Offerings
7.8.5 Agilent Recent Development
8 Industry Chain Analysis
8.1 Cytogenetic Arrays Industrial Chain
8.2 Cytogenetic Arrays Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cytogenetic Arrays Sales Model
8.5.2 Sales Channel
8.5.3 Cytogenetic Arrays Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Illumina
Thermo Fisher
Oxford Nanopore
PacBio
Roche
PerkinElmer
SHBIO
Agilent

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂